Abstract P6-11-02: Efficacy of Hsp90 inhibitor ganetespib plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 trial
Year: 2017
Type: conference-abstract
Source: Cancer Research
Authors: A Forero, D Yee, MB Buxton, WF Symmans, AJ Chien, JC Boughey, AD Elias, A DeMichele, S Moulder, S Minton, HG Kaplan, KS Albain, AM Wallace, BB Haley, C Isaacs, LA Korde, R Nanda, JE Lang, KA Kemmer, NM Hylton, M Paoloni, L van't Veer, J Lyandres, J Perlmutter, M Hogarth, C Yau, A Sanil, DA Berry, LJ Esserman
Institutions: University of Minnesota, University of Denver, Mayo Clinic, University of Arizona, University of California, San Francisco, University of Washington, Moffitt Cancer Center, University of Alabama at Birmingham, University of California San Diego, University of Chicago, University of Pennsylvania, University of California, Davis
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2592994667